Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors

Renata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, Irene Guijarro, Jing Wang, Patrick Zweidler-McKay, Diana Bell, William N. William, Bonnie S. Glisson, Michael J. Wick, Ann M. Kapoun, Amita Patnaik, Gail Eckhardt, Pamela Munster, Leonardo Faoro, Jakob Dupont, J. Jack Lee, Andrew Futreal, Adel K. El-Naggar, John V. Heymach

Research output: Contribution to journal › Article › peer-review

157 Scopus citations

Fingerprint

Dive into the research topics of 'Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences